
Reset all filters
01 2Gowling WLG
Reset all filters
01 22370466
Reset all filters
01 1TRASTUZUMAB EMTANSINE
02 1trastuzumab emtansine
Reset all filters
01 1POWDER FOR SOLUTION
02 1Powder for Solution
Reset all filters
01 22020-06-23
Patent Expiration Date : 2020-06-23
Date Granted : 2011-02-08
Brand Name : KADCYLA
Patent Number : 2370466
Filing Date : 2000-06-23
Strength per Unit : 20 mg / mL
Dosage Form : Powder for Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-06-23
Date Granted : 2011-02-08
Patent Expiration Date : 2020-06-23
Date Granted : 2011-02-08
Brand Name : KADCYLA
Patent Number : 2370466
Filing Date : 2000-06-23
Strength per Unit : 20 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-06-23
Date Granted : 2011-02-08
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF